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Abstract 
 
Background & Objectives : Extra pulmonary tuberculosis (EPTB) constitutes 15 to 20% of total cases of 
tuberculosis in India.  It is high in incidence among HIV and Pediatric group and involves almost all systems of the 
body.  Cbnaat (Catridge-based nucleic acid amplification test) is of definitive value in its diagnosis.  The present 
study aims at knowing the prevalence of EPTB among the population of Visakhapatnam of North Andhra. Material 
& methods:  12,372 cases of EPTB out of total cases (old & new) of 67,017 are studied from the data at District 
Tuberculous Center, Visakhapatnam for the period 2007 to Aug 2018.  Results & Discussion: FNAC samples of 
lymph nodes and others reported highest (177) among EPTB followed by pleural effusion (28) and pus & abscess 
(30) showing similar and bronchial wash (26).  In the present study EPTB showed overall prevalence of 18.80 
similar to Indian average of 15 to 20%.  PTB : EPTB is 4 : 1 in males and 2 : 1 in females showing more in 
incidence in the latter.  Hence the target group for EPTB is more of female population as they are vulnerable due to 
anaemia, malnutrition and low immunity. Conclusion: Though the emphasis is more on PTB case finding, EPTB is 
also significant and has to be paid attention in the control of tuberculosis. 
Keywords : EPTB, Cbnaat, prevalence, percentage, ratio, tuberculosis. 
Introduction 
Tuberculosis is still remains thorn in our soul despite 
intense efforts to control it.  Even today India has the 
highest 7TB burden accounting for 1.9 million cases 
out of 9.1 million globally.  Extra pulmonary 
tuberculosis (EPTB) involves almost every organ 
system in the body.  Its burden ranges from 15 to 20 % 
of all TB cases among HIV –Ve patients and about 40 
to 50% in HIV +Ve new TB patients.  EPTB has 
significant impact on the people and the economy.  
Diagnosis is difficult.  Latest 6Gene-Xpert (Cbnaat) has 
revolutionised the diagnosis of TB particularly EPTB. 
Visakhapatnam city is situated in North Andhra 
Coastal area of Southern India with a population of 
about 45.5  lakhs with 15% tribal. 
_____________________________ 
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Most of the city population are migrants and industrial 
pollution is a matter of concern in this part of the state 
which may be a contributing factor for the high 
incidence of tuberculosis relatively.  EPTB cases are 
noticed at the famous 1200 bedded King George 
Hospital (KGH).   
Present Study 
It Is an observational study of the data collected from 
the District Tuberculous Center (DTC) of 
Visakhapatnam, District in North Andhra which caters 
to the population of the three districts Srikakulam, 
Vizianagaram and Visakhapatnam. About 12,825 new 
cases of EPTB are identified among the total old and 
new cases of  67,017 from 2007 to Aug 2018 from the 
pooled data of DTC.  Tabulated and calculated on 
excel sheet and the relevant health status indicators are 
derived as per bio statistics.  Limitations: Factors like 
HIV status, Diabetes, Anaemia,  alcohol, smoking, 
pollution, slum area problem and co-morbid conditions 
like COPD, CKD, CANCER etc. are not part of the 
present study due to the paucity of data.  The emphasis 
is on the highly sensitive Cbnaat diagnostic result of 
the cases of EPTB.  
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The above map of Visakhapatnam district shows the 20 + TU centers.  The large Green ( Light & Dark ) 
shaded area indicates the tribal belt  which contains 8 TU equal to rural  8 – caters to  14.42% of the total 
population,  largest in the state of AP 
 
Material and Methods  
The material for the study is obtained with permission 
from the district tuberculous officer, Visakhapatnam.  
The method adopted is the tabulation and calculation 
on the excel sheet at the research center of GIMSR.  
The bio-statistician is consulted to adopt the relevant 
statistical methods applied wherever necessary.  The 
health status indicators such as the incidence, 
prevalence, case fatality rate, the failure and default 
rate of EPTB cases among the population of 
Visakhapatnam city and district are considered for the 
study.  The study is done with the permission of the  
 
 
institutional research body on self financing mode as it 
is performed out of our academic interest on such a 
vital topic of tuberculosis.   
 
Bio-statistics  
Certain relevant health status 10indicators like 
prevalence, incidence, PTB-EPTB ratio, case fatality 
rate, relapse rate, failure rate and default rate are 
calculated as per the formulae though the emphasis is 
made on prevalence of EPTB.   
 
 
Table 1: CASE PROFILE DATA 2007 – 2014 
 
YEA
R 
AREA 
NEW 
SPUTUM 
+VE 
NEW 
SPUTU
M -VE 
NEW 
EPT
B 
+VE 
RELAPSE
S 
FAILUR
E 
TA
D 
OTHER
S  
TOTA
L 
CASES 
2007 
URBAN 916 509 533 170 22 30 74 2254 
RURAL 1167 638 357 209 11 17 83 2488 
TRIBA
L 
478 137 46 42 9 7 4 723 
Total : 2561 1284 936 421 42 54 161 5465 
2008 
URBAN 880 591 549 108 15 61 74 2278 
RURAL 1155 537 412 201 17 53 93 2468 
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TRIBA
L 
486 246 98 68 13 16 4 932 
Total : 2521 1374 1059 377 45 130 171 5678 
2009 
URBAN 894 535 434 170 16 26 75 2151 
RURAL 1199 633 410 254 28 60 94 2698 
TRIBA
L 
504 176 77 82 3 6 9 857 
Total : 2597 1344 921 506 47 92 178 5706 
2010 
URBAN 852 593 426 200 25 30 90 2216 
RURAL 1191 651 431 211 35 43 121 2683 
TRIBA
L 
504 219 77 79 17 7 22 925 
Total : 2547 1463 934 490 77 80 233 5824 
2011 
URBAN 921 521 438 199 26 34 104 2243 
RURAL 1232 556 386 222 44 44 124 2608 
TRIBA
L 
543 219 102 77 4 8 25 978 
Total : 2696 1296 926 498 74 86 253 5829 
2012 
URBAN 877 426 489 143 11 21 117 2084 
RURAL 1294 573 391 175 20 32 116 2601 
TRIBA
L 
624 340 142 63 10 20 20 1219 
Total : 2795 1339 1022 381 41 73 253 5904 
2013 
URBAN 947 397 494 165 20 25 89 2137 
RURAL 1284 463 370 171 12 27 115 2442 
TRIBA
L 
536 216 116 73 9 16 21 987 
Total : 2767 1076 980 409 41 68 225 5566 
2014 
URBAN 946 404 478 247 28 29 127 2259 
RURAL 1347 527 382 248 15 32 107 2658 
TRIBA
L 
679 150 145 81 15 38 24 1132 
Total : 2972 1081 1005 576 58 99 258 6049 
Relapse= reporting TB after complete treatment.                                                                                                                        
Failure = Sputum +ve in the middle of treatment.                                                                                                                             
TAD = Treatment after default. 
 
Table 2:Year and prevalence rate 
 
YEAR 
TU 
REGION 
POPULATION AT 
RISK 
NEW EPTB 
CASES 
PREVALENCE RATE/         
1 LAKH 
2015 
URBAN 27,69,383 660 23.83 
RURAL 19,77,979 304 15.37 
TRIBAL 10,15,082 150 14.78 
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TOTAL :  57,62,444 1,114 19.33 
2016 
URBAN 21,78,359 768 35.26 
RURAL 15,89,463 341 21.45 
TRIBAL 6,72,621 156 23.19 
TOTAL :  44,40,443 1,265 28.49 
2017 
URBAN 21,93,299 732 33.37 
RURAL 16,00,368 398 24.87 
TRIBAL 6,77,242 184 27.17 
TOTAL :  44,70,909 1,314 29.39 
Aug-18 
URBAN 21,93,299 580 26.44 
RURAL 16,00,368 238 14.87 
TRIBAL 6,77,242 78 11.52 
TOTAL :  44,70,909 896 20.04 
TOTAL : 4,589 24.31 
 
 
Table 3: CHANGING TREND OF TB PREVALENCE  FROM 2007 TO 2018 - VISAKHAPATNAM 
DISTRICT IN ANDHRA PRADESH 
 
CHANGING TREND OF TB PREVALENCE  FROM 2007 TO 2018 - 
VISAKHAPATNAM DISTRICT IN ANDHRA PRADESH 
YEAR POPULATION AT RISK CASES OLD & NEW PREVALENCE 
2007 4069450 5465 134.29 
2008 4112740 5678 138.06 
2009 4155178 5706 137.32 
2010 4202021 5824 138.60 
2011 4240606 5829 137.46 
2012 4318579 5904 136.71 
2013 4349045 5566 127.98 
2014 4351557 6049 139.01 
2015 5762444 6073 115.00 
2016 4440443 6076 144.46 
2017 4470909 5614 134.80 
2018 4470909 3233 74.36 
Total old & new cases : 67017 
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Table  4: EPTB CASE STATISTICS FROM 2007 TO AUG 2018 OF VISAKHAPATNAM DISTRICT 
 
EPTB CASE STATISTICS FROM 2007 TO AUG 2018 OF VISAKHAPATNAM 
DISTRICT 
YEAR NEW CASES 
EPTB 
OUT OF 
NEW 
CASES 
EPTB % OUT 
OF NEW 
CASES 
TOTAL 
CASES                                      
(OLD & 
NEW) 
EPTB % 
OF
TOTAL 
CASES 
2007 4781 936 19.58 5465 17.12 
2008 4954 1059 21.37 5678 18.67 
2009 4862 921 18.94 5706 16.14 
2010 4944 934 18.89 5824 16.04 
2011 4918 926 18.82 5829 15.88 
2012 5156 1022 19.82 5908 17.30 
2013 4823 980 20.31 5566 17.60 
2014 5058 1005 19.86 6049 16.61 
2015 5079 1114 21.93 6073 18.34 
2016 5096 1265 24.82 6086 20.78 
2017 4759 1314 27.61 5614 23.40 
Aug-18 2799 896 32.00 3233 27.71 
Total : 57229 12372 22.00 67017 18.80 
 
Table 5: GENDER DISTRIBUTION OF PTB & EPTB AND THE RATIO 
GENDER DISTRIBUTION OF PTB & EPTB AND THE RATIO 
YEAR SEX PTB EPTB EPTB  % PTB : EPTB 
2015 
MALE 2672 547 20.47 4.88 : 1 
FEMALE 1293 567 43.85 2.28 : 1 
TOTAL 3965 1114 28.10 3.56 : 1 
2016 
MALE 2587 635 24.55 4.07 : 1 
FEMALE 1244 630 50.64 1.97 : 1 
TOTAL 3831 1265 33.02 3.03 : 1 
2017 
MALE 2441 683 27.98 3.57 : 1 
FEMALE 1004 631 62.85 1.59 : 1 
TOTAL 3445 1314 38.14 2.62 : 1 
2018 
MALE 1860 706 37.96 2.63 : 1 
FEMALE 917 643 70.12 1.43 : 1 
TOTAL 2777 1349 48.58 2.06 : 1 
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CBNAAT DATA  
EPTB – CBNaat samples at DTC & KGH – from 2016 TO 2018 
2016 - 240 samples 
2017 - 492 samples 
2018 - 905 samples 
Total - 1637 samples  
EPTB – CBNaat samples at District Hospital – RJY from 2017, 2018 
2017 – total samples - 112  
 RIF – Sensitive - 46 
 RIF – Resistant - 2 
2018 - total samples - 178 
 RIF – Sensitive - 59 
 RIF – Resistant - 2 
The above data from Rajahmundry (RJY), AP shows Rifampcin resistance of 4.34 in 2017 and 3.39 in 2018. 
 
Table 6: EPTB - CBNAAT  DISEASE  PROFILE OF  VISAKHAPATNAM  FOR 2016,2017,2018 
EPTB - CBNAAT  DISEASE  PROFILE OF  VISAKHAPATNAM  FOR 2016,2017,2018 
Sample type CBNAAT tested Rifampcin sensitive Rifampcin  resistant 
12FNAC (lymph node, thyroid, 
parotid, breast, tumours etc. ) 
622 177 8 
Pleural effusion 265 28 1 
Pus & abscess  123 30 3 
Ascitic fluid 123 4 0 
Bone & joint 102 15 1 
Csf 135 4 1 
Gastric lavage 135 3 - 
Bronchial wash 94 26 1 
Endometrial 9 1   
Biopsy  26 2 0 
Hydrocele fluid 2 - - 
Drain site fluid 1 - - 
Total : 1637 290 15 
The above CBNAAT sample data is collected from two main centers, DTC & KGH. Rifampcin resistance is 
5% of total TB samples tested +Ve with Cbnaat. 
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Fig 1:  Bar Diagram showing the RIF sensitive and resistant on Cbnaat – Frequency distribution. 
 
Table 7: RIFAMPCIN RESISTANCE - IN INDIA - 2016 
 
RIFAMPCIN RESISTANCE - IN INDIA - 2016 
NEW TB CASES 20% 
IN PREVIOUSLY TREATED TB PATIENTS 67% 
IN NOTIFIED TB PATIENTS 41% 
 
Results  
Detailed case profile data of PTB & EPTB is shown in 
Table-1 for the period 2007 to 2014.  As per table – 2, 
the prevalence of EPTB among urban, rural and tribal 
areas of Visakhapatnam shows an increasing trend 
from 2015 to Aug 2018, rate ranging from 19.33 in 
2015 to 29.39 in 2017.  The average prevalence for the 
period 92015 to 2018 is 24.31 per one lakh population.  
The overall prevalence of total TB including PTB plus 
EPTB from 2007 to 2018 is about 135(Table – 3).  
EPTB percentage of total cases (Old & New) is about 
18.80%  for the period 2007 to 2018(Table-4).  Hence,  
the EPTB share of total TB cases is similar to Indian 
average of 15 to 20%.  Table – 5 shows the PTB : 
EPTB gender ratio in males is about 4:1 but in females 
it is 2:1 for the period of study 2015 to 2018.  The 5C B 
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N A A T diagnostic results confine to 2 to 3 years for 
2016,2017,2018, as this Gene-Xpert has come into 
force recently throughout India, yet not spread widely.  
The present sample study shows EPTB of lymph node 
(FNAC) maximum in occurrence followed by abscess 
and pleural taking next.  The Rifampcin resistance in 
the present study population is 4 – 5%(Table-6) far less 
than Indian average(Table-7).  The bar diagram-1 gives 
a telltale picture of Rifampcin sensitivity pattern of  
different diseases of EPTB.  Out of total 1637 samples 
received for Cbnaat testing at DTC and KGH, 290 are 
+Ve for EPTB Rifampcin sensitive and 15 resistant, 
sample size is increasing gradually.  Which shows the 
improved awareness among medical personnel towards 
the definitive diagnosis of tuberculosis.   This trend 
shows better compliance of the treatment of 
tuberculosis esp. EPTB.  The Cbnaat profile when 
compared Visakhapatnam to another center 
Rajahmundry shows similar trend.  Hence the pattern is 
almost same in the state of Andhra Pradesh. The failure 
rate and the default rate of all cases of TB from 2007 to 
2014 is 16% and 1.5% respectively,  and the case 
fatality rate maintains at 1.5%  for the period 2015 to 
2018. 
Discussion  
Often EPTB diagnosis depends upon strong clinical 
suspicion by the doctor.  Surprisingly, most of the 
clinicians/specialists are not aware of importance of the 
high sensitive genetic test like the Cbnaat.  General 
feeling medical fraternity is TB means PTB but EPTB 
is no less common and it is very high even upto 50% 
among HIV +ve people effected with TB due to 
reactivation as the immunity is compromised  in them.  
Surgical implications of EPTB is an important 
consideration as 8ATT may cure the disease but leaves 
the residual sequelae like adhesions of intestines, 
obstruction to CSF flow, lung fibrosis, bone loss etc.  
EPTB is often clinical than epidemiological. 1,2 
Other studies : As per Pooja Singh Gour retrospective 
study  in 2017 in North India of 552 patients, 252 are 
EPTB cases which are more common in female gender 
in the age group 31 to 40 years, and in males between 
41 to 50 years. Co-infection is often reported with 
4diabetes and HIV  and only 12% are retreatment cases 
which is 24% in PTB.  MDR is more often reported 
with PTB.  Pleural followed by lymph node is the 
pattern of EPTB in their study and even in the present 
study FNAC is followed by abscess and pleural 
equally.  Another recent study by Anita Velingker from 
Goa for the period 2013 to 2015 of 1,598 cases 
revealed 31% incidence of EPTB cases with 47% 
among HIV +Ve with diabetes.  Here also pleural is 
followed by lymphatic in the incidence maximum 
among 30 to 50 years age group.   
Conclusion 
The prevalence of  EPTB maintains a plateau without 
much fluctuations over years as per the present study.  
The case burden is more in the society as they are not 
suspected and not referred to Cbnaat centers.  11With 
the establishment of more and more of Gene-Xpert 
machines network allover the areas, EPTB case load 
can cross the tip of the iceberg coming to the surface.  
Provision has to be made in 3RNTCP in this aspect. 
There is no separate emphasis on EPTB control by the 
RNTCP.  Hence all the hospitals (both private & govt)  
have to be directed by the G.O.I. to tackle cases of 
EPTB in co-ordination with the control agencies.  
EPTB resulting in surgery has to be done free of cost or 
at gross concession at all private hospitals.  A special 
provision has to be made through the health insurance 
scheme.  It has to be made compulsory for all private 
hospitals to purchase Gene-Xpert so that more cases of 
EPTB can be diagnosed and the drug treatment can be 
provided by the govt. nodal agencies.  
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